Videos

Given there is not a clear international standard for health records, one of the challenges in the early COVID-19 response mobilization was a delayed start to data collection and indexing.

Some countries have been proactive in patient logging and tracking. How can even retroactive assessment benefit future preventive responses?

A look at 3 major headlines in COVID-19 news on June 15, 2020.

Trending infectious disease news.

A brief on today's top ID stories.

Patrick Soon-Shiong, MD, describes goals and expectations for the accelerated coronavirus vaccine program Operation Warp Speed.

A brief update on today's infectious disease news.

Patrick Soon-Shiong, MD, explains why an ImmunityBio SARS-CoV-2 vaccine candidate uses Nucleocapsid DNA alongside Spike DNA.

A quick brief on today's top infectious disease news.

Jason Pogue, PharmD, BCPS, BCIDP, speaks about the state of publishing during the COVID-19 pandemic.

A brief on today's top ID news.

Jason Pogue, PharmD, BCPS, BCIDP, answers questions about the emerging picture for hydroxychloroquine.

John Strotbeck, CEO of Boathouse Sports, discusses results of physical distancing measures at the firm's COVID-adapted factory.

Adam Brufsky, MD, PhD, addresses the potential for changing dynamics in SARS-CoV-2.

A brief on the latest infectious disease headlines.

Matthew F. Pullen, MD, co-author of the recent hydroxychloroquine prophylaxis trial, shares the top clinical takeaways.

Why people may need to readjust their expectations around COVID-19 clinical data and drugs.

John Strotbeck, Olympian and CEO of Boathouse Sports, explains how and why the outerwear company pivoted to PPE production at the start of the COVID-19 pandemic.

A review of the latest infectious disease news.

Sarah Jorgensen, PharmD, MPH, BCPS, BCIDP, AAHIVP, provides a deep dive on the pharmacology and biochemistry of remdesivir.

A look at the means by which clinicians are quantifying and evaluating the effects of the antiviral drug.

It's been one month since the antiviral therapy was granted emergency use authorization. How has it affected COVID-19 care?

A daily infectious disease news update

Kelly Cawcutt, MD, MS, shares her thoughts on COVID's impact on health care, as well as why it's so important for clinicians to take breaks.

A brief on our top stories from May 28, 2020.

Debbie Goff, PharmD, describes how antimicrobial stewardship work has continued during the COVID-19 pandemic.

A daily news update on our COVID-19 coverage.

Helen W. Boucher, MD, FACP, FIDSA, discusses the need for a transparent distribution process for remdesivir, plus COVID disparities, secondary infections, and what “the new normal” of health care looks like.